Ambrosia Biosciences
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$25M
Ambrosia Biosciences develops orally delivered, small molecule-based therapies for obesity and metabolic disorders.
Focus Areas
drug discovery
small molecule therapies
obesity
metabolic disorders
incretins
class B GPCRs
Investors
